Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 - Arcutis Biotherapeutics (NASDAQ:ARQT)
WESTLAKE VILLAGE, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology,